betulinic acid has been researched along with Neoplasms in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.22) | 18.2507 |
2000's | 11 (24.44) | 29.6817 |
2010's | 25 (55.56) | 24.3611 |
2020's | 8 (17.78) | 2.80 |
Authors | Studies |
---|---|
Fujii, N; Mahindroo, N; Punchihewa, C | 1 |
Barthel, A; Csuk, R; Kluge, R; Kommera, H; Paschke, R; Ströhl, D | 1 |
Eiznhamer, DA; Flavin, MT; Flavin, WP; Koohang, A; Mar, AA; Szotek, EL; Xu, ZQ | 1 |
Han, J; He, WJ; Ji, CJ; Tan, NH; Zeng, GZ; Zhang, YM | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Alho, DPS; Figueiredo, SAC; Gonçalves, BMF; Leal, AS; Mendes, VIS; Salvador, JAR; Silvestre, SM; Valdeira, AS | 1 |
Csuk, R; Fischer, L; Rohmer, M; Wiemann, J | 1 |
Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
Borkova, L; Hodon, J; Kazakova, A; Pokorny, J; Urban, M | 1 |
Miao, Z; Wang, C; Wang, Y; Wu, Y; Ye, S; Zhang, H; Zhang, Y; Zhu, Y | 1 |
Abzaliyeva, S; Bazarbayeva, A; Farooqi, AA; Kapanova, G; Tashenova, G; Tulebayeva, A; Turgambayeva, A | 1 |
Abdullin, TI; Idrisova, LR; Ishkaeva, RA; Kundina, AV; Laikov, AV; Mironov, VF; Nemtarev, AV; Salikhova, TI; Tikhomirova, MV; Tsepaeva, OV | 1 |
Chen, H; Dai, Z; Gao, F; Gu, Y; Han, N; Huo, S; Lei, H; Li, W; Liu, X; Qi, J; Tian, X; Wang, P; Wu, Q; Xie, T; Yang, Y | 1 |
Cheng, J; Han, Y; Li, X; Wang, S; Yang, X; Zhao, H | 1 |
Akinyelu, J; Daniels, A; Oladimeji, O; Singh, M | 1 |
Haeri, HH; Hinderberger, D; Hussain, H; Kaluđerović, GN; Morgan, I; Roos, AH; Sultani, HN; Westermann, B | 1 |
Dong, S; Jiang, W; Li, X; Zhou, W | 1 |
Bhadauria, AS; Kumar, P; Saha, S; Singh, AK | 1 |
Bori, ID; Hung, HY; Iida, A; Lee, KH; Nakagawa-Goto, K; Qian, K; Suzuki, N; Tokuda, H | 1 |
Baratto, LC; Emmerich, D; Paschke, R; Schmidt, H; Vanchanagiri, K | 1 |
Dehelean, C; Duicu, O; Gheorgheosu, D; Muntean, D; Soica, C | 1 |
Csuk, R | 1 |
Chinthakindi, PK; Hamid, A; Koul, S; Majeed, R; Mintoo, MJ; Mondhe, DM; Rath, SK; Rayees, S; Sangwan, PL; Saxena, AK; Singh, G; Singh, SK | 1 |
Airoldi, FP; Araújo, BQ; Citó, AM; Ferreira, PM; Lima, DJ; Monção, NB; Pessoa, C; Silva, Jdo N | 1 |
Chinthakindi, PK; Hamid, A; Hussain, A; Khan, I; Koul, S; Majeed, R; Sangwan, PL; Saxena, AK; Sharma, PR | 1 |
Aleshunin, PA; Chytil, P; Etrych, T; Filippov, SK; Janoušková, O; Lomkova, EA; Lucas, H; Mueller, T; Skorik, YA; Trhlíková, O; Ulbrich, K | 1 |
Günther, G; Morales, J; Rodríguez, L; Valdés, K | 1 |
Bramucci, M; Dall'Acqua, S; Ferrari, S; Gandin, V; Maggi, F; Mártonfi, P; Peron, G; Quassinti, L | 1 |
Chang, FR; Chen, IH; Chen, SL; Chiang, MY; Du, YC; Hwang, TL; Lin, AS; Lin, CR; Lübken, T; Wu, CC; Wu, YC; Yen, MH | 1 |
Fulda, S; Kroemer, G | 1 |
Chan, KL; Majid, AM; Ng, KW; Salhimi, SM | 1 |
Fulda, S | 1 |
Barthel, A; Csuk, R; Schwarz, S; Sczepek, R; Siewert, B | 1 |
Fang, X; Guo, X; He, K; Jin, YH; Li, Q; Li, Y; Sun, C; Wang, X; Zhan, Z | 1 |
Chen, CH; Huang, L; Hung, HY; Kim, SY; Lee, KH; Qian, K | 1 |
Ahmad, FJ; Awasthi, A; Jaggi, M; Mishra, G; Singh, AT; Singh, MK | 1 |
Cichewicz, RH; Kouzi, SA | 1 |
Eiznhamer, DA; Xu, ZQ | 1 |
Debatin, KM; Fulda, S | 1 |
Dzubak, P; Hajduch, M; Klinotova, E; Kvasnica, M; Sarek, J | 1 |
Behrend, L; Debatin, KM; Fulda, S; Kasperczyk, H; La Ferla-Brühl, K; Westhoff, MA; Zwacka, RM | 1 |
Kaczor, J; Kandefer-Szerszeń, M; Rzeski, W; Sifringer, M; Stepulak, A; Szymański, M; Wejksza, K; Zdzisińska, B | 1 |
de Roo, GM; Kessler, JH; Medema, JP; Mullauer, FB | 1 |
Cmoch, P; Pakulski, Z; Strnad, M; Swaczynová, J | 1 |
Cho, KH; Chung, SM; Das Gupta, TK; Graham, J; Pezzuto, JM; Shin, YG | 1 |
15 review(s) available for betulinic acid and Neoplasms
Article | Year |
---|---|
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
Topics: Antineoplastic Agents; Drug Discovery; Hedgehog Proteins; Humans; Neoplasms; Signal Transduction; Transcription Factors; Zinc Finger Protein GLI1 | 2009 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Humans; Indolequinones; Neoplasms; Oleanolic Acid; Structure-Activity Relationship; Triterpenes | 2017 |
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antiviral Agents; Biomedical Research; Cell Proliferation; Drug Design; Humans; Neoplasms; Triterpenes; Viruses | 2019 |
Multifunctional Roles of Betulinic Acid in Cancer Chemoprevention: Spotlight on JAK/STAT, VEGF, EGF/EGFR, TRAIL/TRAIL-R, AKT/mTOR and Non-Coding RNAs in the Inhibition of Carcinogenesis and Metastasis.
Topics: Animals; Antineoplastic Agents; Betulinic Acid; Carcinogenesis; Epidermal Growth Factor; ErbB Receptors; Neoplasms; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2022 |
Betulinic acid in the treatment of tumour diseases: Application and research progress.
Topics: Animals; Antineoplastic Agents, Phytogenic; Betula; Betulinic Acid; Humans; Neoplasms; Oxidative Stress; Pentacyclic Triterpenes; Signal Transduction | 2021 |
Betulinic acid as apoptosis activator: Molecular mechanisms, mathematical modeling and chemical modifications.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Humans; Mitochondria; Models, Theoretical; Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2018 |
Betulinic acid as a potent and complex antitumor phytochemical: a minireview.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Humans; Neoplasm Metastasis; Neoplasms; Pentacyclic Triterpenes; Phytochemicals; Triterpenes | 2014 |
Betulinic acid and its derivatives: a patent review (2008-2013).
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Line, Tumor; Drug Design; Humans; Neoplasms; Patents as Topic; Pentacyclic Triterpenes; Solubility; Structure-Activity Relationship; Triterpenes | 2014 |
Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.
Topics: Animals; Antineoplastic Agents; Betulinic Acid; Biological Availability; Drug Delivery Systems; Drug Liberation; Humans; Nanocapsules; Neoplasms; Oleanolic Acid; Pentacyclic Triterpenes; Solubility; Triterpenes; Unilamellar Liposomes; Ursolic Acid; Water | 2016 |
Targeting mitochondrial apoptosis by betulinic acid in human cancers.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Drug Resistance, Neoplasm; Humans; Mitochondrial Membranes; Models, Biological; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2009 |
Modulation of apoptosis by natural products for cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Clinical Trials as Topic; Gossypol; Humans; Mitochondria; Neoplasms; Pentacyclic Triterpenes; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Triterpenes; Vitamin E | 2010 |
Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
Topics: Animals; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Betulinic Acid; HIV Infections; Humans; Mass Spectrometry; Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2004 |
Betulinic acid: a promising anticancer candidate.
Topics: Animals; Antineoplastic Agents; Betulinic Acid; Drugs, Investigational; Humans; Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2004 |
30 other study(ies) available for betulinic acid and Neoplasms
Article | Year |
---|---|
Synthesis and biological evaluation of antitumour-active betulin derivatives.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triterpenes | 2010 |
Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoids.
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cytotoxins; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes | 2010 |
Zizimauritic acids A-C, three novel nortriterpenes from Ziziphus mauritiana.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Neoplasms; Plant Roots; Staphylococcal Infections; Staphylococcus aureus; Triterpenes; Ziziphus | 2012 |
Syntheses of C-ring modified dehydroabietylamides and their cytotoxic activity.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Neoplasms; Structure-Activity Relationship | 2018 |
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors.
Topics: 5'-Nucleotidase; Adenosine; Betulinic Acid; Humans; Immunotherapy; Neoplasms; Pentacyclic Triterpenes | 2022 |
Bifunctionalized Betulinic Acid Conjugates with C-3-Monodesmoside and C-28-Triphenylphosphonium Moieties with Increased Cancer Cell Targetability.
Topics: Betulinic Acid; Chromatography, Liquid; Glycosides; Humans; Male; Mannose; Neoplasms; Rhamnose; Tandem Mass Spectrometry; Triterpenes | 2023 |
Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
Topics: Antineoplastic Agents; Betulinic Acid; Cytotoxins; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Neoplasms; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes | 2020 |
Carrier-Free Triterpene Prodrugs with Glutathione Response and Biosafety for Synergistically Enhanced Photochemotherapy.
Topics: Animals; Antineoplastic Agents; Betulinic Acid; Chlorophyllides; Density Functional Theory; Drug Synergism; Female; Glutathione; Light; Mice, Inbred BALB C; Models, Chemical; Molecular Dynamics Simulation; Nanoparticles; Neoplasms; Pentacyclic Triterpenes; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prodrugs; Singlet Oxygen; Stigmasterol | 2021 |
Modified Gold Nanoparticles for Efficient Delivery of Betulinic Acid to Cancer Cell Mitochondria.
Topics: Apoptosis; Betulinic Acid; Caco-2 Cells; Cell Cycle; Cell Proliferation; Drug Delivery Systems; Gold; HeLa Cells; Humans; MCF-7 Cells; Metal Nanoparticles; Mitochondria; Neoplasms; Pentacyclic Triterpenes | 2021 |
Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions.
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cholic Acid; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Fusidic Acid; Humans; Neoplasms; Pentacyclic Triterpenes; Small Molecule Libraries; Spin Labels; Steroids; Triterpenes | 2021 |
A-ring modified betulinic acid derivatives as potent cancer preventive agents.
Topics: Animals; Anticarcinogenic Agents; Betulinic Acid; Cell Line; Herpesvirus 4, Human; Humans; Mice; Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2014 |
Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cisplatin; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes | 2014 |
Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.
Topics: Animals; Apoptosis; Betulinic Acid; Cell Cycle Checkpoints; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Triterpenes | 2014 |
Assessing chemical constituents of Mimosa caesalpiniifolia stem bark: possible bioactive components accountable for the cytotoxic effect of M. caesalpiniifolia on human tumour cell lines.
Topics: Antineoplastic Agents, Phytogenic; Betulinic Acid; Cell Survival; Flavonoids; Humans; Mimosa; Neoplasms; Pentacyclic Triterpenes; Phenols; Plant Bark; Plant Extracts; Triterpenes; Tumor Cells, Cultured | 2015 |
PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.
Topics: Betulinic Acid; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HL-60 Cells; Humans; MCF-7 Cells; Neoplasms; Pentacyclic Triterpenes; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Signal Transduction; Triazoles; Triterpenes | 2016 |
Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.
Topics: Animals; Betulinic Acid; Biodegradable Plastics; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Humans; Methacrylates; Mice; Micelles; Neoplasms; Pentacyclic Triterpenes; Polymers; Triterpenes | 2016 |
Phytochemical investigations and antiproliferative secondary metabolites from Thymus alternans growing in Slovakia.
Topics: Antineoplastic Agents, Phytogenic; Betulinic Acid; Cell Proliferation; Chromatography, High Pressure Liquid; Cisplatin; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; HCT116 Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Neoplasms; Oils, Volatile; Pentacyclic Triterpenes; Phytochemicals; Phytotherapy; Plant Components, Aerial; Plant Extracts; Plant Oils; Plants, Medicinal; Slovakia; Thymus Plant; Triterpenes | 2017 |
Acasiane A and B and farnesirane A and B, diterpene derivatives from the roots of Acacia farnesiana.
Topics: Acacia; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Betulinic Acid; Cell Line, Tumor; Diterpenes; Flavonoids; Humans; Leukocyte Elastase; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Plant Extracts; Plant Roots; Superoxides; Triterpenes | 2009 |
Anti-angiogenic and cytotoxicity studies of some medicinal plants.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Betulinic Acid; Cell Line, Tumor; Endothelial Cells; Humans; Lignans; Neoplasms; Pentacyclic Triterpenes; Plant Extracts; Plants, Medicinal; Rats; Triterpenes; Umbilical Veins | 2010 |
Synthesis, encapsulation and antitumor activity of new betulin derivatives.
Topics: Antineoplastic Agents; Betulinic Acid; Cell Line, Tumor; Colorimetry; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Liposomes; Neoplasms; Pentacyclic Triterpenes; Pyrazoles; Rhodamines; Structure-Activity Relationship; Triazoles; Triterpenes | 2011 |
Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Betulinic Acid; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Flow Cytometry; Ginsenosides; HeLa Cells; Hep G2 Cells; Humans; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Protein Transport; RNA Interference; Triterpenes | 2011 |
New betulinic acid derivatives as potent proteasome inhibitors.
Topics: Antineoplastic Agents; Betulinic Acid; Chymotrypsin; Cysteine Proteinase Inhibitors; Drug Design; Inflammation; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Pentacyclic Triterpenes; Proteasome Inhibitors; Signal Transduction; Structure-Activity Relationship; Triterpenes | 2011 |
Application of a liquid chromatography-electrospray mass spectrometry (LC/MS) method to the biodistribution and excretion studies of novel 5'-chloro-2, 3-didehydroindolo (2', 3': 2, 3) betulinic acid (DRF-4012) in tumour-bearing mice.
Topics: Animals; Betulinic Acid; Calibration; Cell Line, Tumor; Chromatography, Liquid; Drug Stability; Humans; Indoles; Injections, Intravenous; Male; Mice; Mice, Nude; Nanoparticles; Neoplasms; Pentacyclic Triterpenes; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution; Triterpenes; Xenograft Model Antitumor Assays | 2013 |
Sensitization for anticancer drug-induced apoptosis by betulinic Acid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Caspases; Cells, Cultured; Cisplatin; Complement Membrane Attack Complex; Complement System Proteins; Cytochromes c; Dactinomycin; Doxorubicin; Drug Synergism; Enzyme Activation; Etoposide; Fibroblasts; Glycoproteins; Humans; Membrane Potentials; Mitochondria; Mutation; Neoplasms; Paclitaxel; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2005 |
Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity.
Topics: Acylation; Antineoplastic Agents; Betulinic Acid; Cell Survival; Drug Screening Assays, Antitumor; Esters; Humans; Neoplasms; Pentacyclic Triterpenes; Phthalic Acids; Triterpenes; Tumor Cells, Cultured | 2005 |
Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy.
Topics: Apoptosis; Base Sequence; Betulinic Acid; Cell Line, Tumor; DNA Primers; Humans; Hydrolysis; I-kappa B Proteins; Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Pentacyclic Triterpenes; Triterpenes | 2005 |
Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Humans; Neoplasms; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Triterpenes | 2006 |
Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Jurkat Cells; Lung Neoplasms; Male; Neoplasms; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Triterpenes; Uterine Cervical Neoplasms | 2007 |
Synthesis of lupane-type saponins bearing mannosyl and 3,6-branched trimannosyl residues and their evaluation as anticancer agents.
Topics: Antineoplastic Agents; Betulinic Acid; Cell Survival; Cells, Cultured; Fibroblasts; Humans; Mannose; Mannosides; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Saponins; Triterpenes | 2008 |
Determination of betulinic acid in mouse blood, tumor and tissue homogenates by liquid chromatography-electrospray mass spectrometry.
Topics: Animals; Betulinic Acid; Calibration; Chromatography, High Pressure Liquid; Humans; Kidney; Liver; Lung; Mass Spectrometry; Mice; Mice, Nude; Neoplasms; Pentacyclic Triterpenes; Triterpenes | 1999 |